Single cells tell multiple tales in CML

David M. Ross

doi:10.1182/blood.2023020165

Single cells tell multiple tales in CML

David M. Ross

Research output: Contribution to journal › Editorial

1 Citation (Scopus)

Abstract

In this issue of Blood, Krishnan et al describe a single-cell transcriptomic atlas of chronic myeloid leukemia (CML) at diagnosis.1 By comparing groups with varying degrees of response or treatment failure on imatinib, they identified cellular features at diagnosis that were predictive of response to tyrosine kinase inhibitor (TKI) therapy...

Original language	English
Pages (from-to)	2668-2670
Number of pages	3
Journal	Blood
Volume	141
Issue number	22
DOIs	https://doi.org/10.1182/blood.2023020165
Publication status	Published - 1 Jun 2023
Externally published	Yes

Keywords

Chronic myeloid leukemia (CML)
tyrosine kinase inhibitors (TKIs)
imatinib resistance

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood.2023020165Licence: In Copyright

Cite this

@article{8571d4cb8f0f4a769b29804e10a77606,

title = "Single cells tell multiple tales in CML",

abstract = "In this issue of Blood, Krishnan et al describe a single-cell transcriptomic atlas of chronic myeloid leukemia (CML) at diagnosis.1 By comparing groups with varying degrees of response or treatment failure on imatinib, they identified cellular features at diagnosis that were predictive of response to tyrosine kinase inhibitor (TKI) therapy...",

keywords = "Chronic myeloid leukemia (CML), tyrosine kinase inhibitors (TKIs), imatinib resistance",

author = "Ross, {David M.}",

year = "2023",

month = jun,

day = "1",

doi = "10.1182/blood.2023020165",

language = "English",

volume = "141",

pages = "2668--2670",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "22",

}

TY - JOUR

T1 - Single cells tell multiple tales in CML

AU - Ross, David M.

PY - 2023/6/1

Y1 - 2023/6/1

N2 - In this issue of Blood, Krishnan et al describe a single-cell transcriptomic atlas of chronic myeloid leukemia (CML) at diagnosis.1 By comparing groups with varying degrees of response or treatment failure on imatinib, they identified cellular features at diagnosis that were predictive of response to tyrosine kinase inhibitor (TKI) therapy...

AB - In this issue of Blood, Krishnan et al describe a single-cell transcriptomic atlas of chronic myeloid leukemia (CML) at diagnosis.1 By comparing groups with varying degrees of response or treatment failure on imatinib, they identified cellular features at diagnosis that were predictive of response to tyrosine kinase inhibitor (TKI) therapy...

KW - Chronic myeloid leukemia (CML)

KW - tyrosine kinase inhibitors (TKIs)

KW - imatinib resistance

UR - http://www.scopus.com/inward/record.url?scp=85160444036&partnerID=8YFLogxK

U2 - 10.1182/blood.2023020165

DO - 10.1182/blood.2023020165

M3 - Editorial

C2 - 37261852

AN - SCOPUS:85160444036

SN - 0006-4971

VL - 141

SP - 2668

EP - 2670

JO - Blood

JF - Blood

IS - 22

ER -

Single cells tell multiple tales in CML

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this